EO-3021
UNII CBF5R8TXD9
Substance Identification & Data
This profile provides standardized clinical and technical data for Eo-3021, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CBF5R8TXD9.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
CBF5R8TXD9
N/A
N/A
Detailed Substance Profile
Preferred Name
EO-3021
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Eo-3021. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
Common Names & Synonyms
ANTI-CLAUDIN 18.2 ANTIBODY DRUG CONJUGATE WITH MMAE AND LND1002 LINKER
Technical Codes
EO-3021
